IP Library Granted Patent US 10,752,592
Granted Patent B2
US 10,752,592 · App. 16/363,465 · Granted Aug 25, 2020

Morphan and morphinan analogues, and methods of use

Inventors: Laura Cook Blumberg (Lincoln, MA); Daniel R. Deaver (Franklin, MA); David J. Eyerman (Wayland, MA); Thomas Andrew Wynn (Lexington, MA)
Assignee: ALKERMES PHARMA IRELAND LIMITED
C07D221/28A61K31/485C07D221/26C07D405/06C07D489/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,752,592
App. No.
16/363,465
Granted
Aug 25, 2020
Kind
B2
Abstract

The present application relates to analogues of morphan and morphinan, compositions thereof, and methods for treating a disease or condition comprising administering an effective amount of the compounds or compositions to a subject in need thereof.

Claims (19)

1. A compound of Formula III:

or a pharmaceutically acceptable salt thereof, wherein

R 1 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, cycloalkyl, heterocyclyl, hydroxyalkyl, or alkoxyalkyl;

R 2 and R 3 , together with the carbon atoms to which they are attached, form a 6-membered unsubstituted carbocyclic ring, or a 6-membered carbocyclic ring optionally substituted with a NR 50 R 60 group, wherein R 50 and R 60 are each independently H, alkyl, or substituted acyl;

R 4 and R 5 are each, independently, H, hydroxyl, or taken together with the carbon atom to which they are attach to, form a C═O group;

R 6 is unsubstituted or substituted C 6 -C 10 aryl, or substituted or unsubstituted heteroaryl comprising one or two 5- or 6-membered rings and 1-4 heteroatoms selected from N, O and S; and

R 7 and R 8 are each, independently, H or hydroxyl.

2. The compound of claim 1 , wherein R 1 is C 2 -C 6 alkenyl or cycloalkyl.

3. The compound of claim 2 , wherein R 1 is cyclopropyl or cyclobutyl.

4. The compound of claim 1 , wherein R 2 and R 3 , together with the carbon atoms to which they are attached form a 6-membered unsubstituted carbocyclic ring.

5. The compound of claim 1 , wherein substituted acyl is:

wherein

R 11 is linear or branched C 1 -C 6 alkyl;

R 12 is halo, C 1 -C 6 alkyl, or C 1 -C 6 alkyl alkoxy; and

R 13 is aryl or heteroaryl.

6. The compound of claim 1 , wherein R 4 and R 5 , taken together with the carbon atom to which they are attached, form a C═O group.

7. The compound of claim 1 , wherein R 4 and R 5 are each, independently, H or hydroxyl.

8. The compound of claim 1 , wherein R 6 is substituted heteroaryl comprising one or two 5- or 6-membered rings and 1-4 heteroatoms selected from N, O, and S.

9. The compound of claim 1 , wherein R 6 is unsubstituted or substituted C 6 -C 10 aryl.

Assignments (4)
SECURITY INTEREST Recorded Feb 13, 2026
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 074858/0405 →
RELEASE OF SECURITY INTEREST IN PATENTS PREVIOUSLY RECORDED AT REEL/FRAME (073213/0302) Recorded Feb 13, 2026
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 074858/0429 →
SECURITY INTEREST Recorded Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2019
From: BLUMBERG, LAURA COOK; DEAVER, DANIEL R.; EYERMAN, DAVID J.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 049015/0136 →